Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
Immunotherapies using immune checkpoint inhibitors (ICIs) and chimeric antigen receptor
(CAR) T-cell therapy have achieved successful results against several types of human …
(CAR) T-cell therapy have achieved successful results against several types of human …
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment.
L Zhang, SA Pakmehr, R Shahhosseini… - Medical Oncology …, 2023 - europepmc.org
Immunotherapies using immune checkpoint inhibitors (ICIs) and chimeric antigen receptor
(CAR) T-cell therapy have achieved successful results against several types of human …
(CAR) T-cell therapy have achieved successful results against several types of human …
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
L Zhang, SA Pakmehr, R Shahhosseini… - Medical …, 2024 - acikerisim.medipol.edu.tr
Immunotherapies using immune checkpoint inhibitors (ICIs) and chimeric antigen receptor
(CAR) T-cell therapy have achieved successful results against several types of human …
(CAR) T-cell therapy have achieved successful results against several types of human …
Oncolytic viruses improve cancer immunotherapy by reprogramming solid tumor microenvironment
L Zhang, SA Pakmehr… - Medical oncology …, 2023 - pubmed.ncbi.nlm.nih.gov
Immunotherapies using immune checkpoint inhibitors (ICIs) and chimeric antigen receptor
(CAR) T-cell therapy have achieved successful results against several types of human …
(CAR) T-cell therapy have achieved successful results against several types of human …